Clinical trials
Epilepsies, Myoclonic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 7 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 10 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| No longer available | 4 |
| Approved for marketing | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
| Available | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jazz Pharmaceuticals | 6 |
| Longboard Pharmaceuticals | 5 |
| Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 5 |
| Takeda | 4 |
| Stoke Therapeutics, Inc | 3 |
| University of Colorado, Denver | 3 |
| Amgen | 2 |
| Cook Children's Health Care System | 2 |
| Eisai Inc. | 2 |
| Encoded Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsies, Myoclonic | 61 |
| Epilepsy | 24 |
| Lennox Gastaut Syndrome | 16 |
| Seizures | 16 |
| Tuberous Sclerosis | 7 |
| Brain Diseases | 5 |
| Anemia, Sickle Cell | 2 |
| Cystic Fibrosis | 2 |
| Diabetes Mellitus | 2 |
| Drug Resistant Epilepsy | 2 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.